Radial Versus Femoral Secondary Access in Patients Undergoing TAVI

NCT07399392 | Recruiting DMC

• 1 other identifier: 25-1058-S1
• Study Type: interventional
• Target: 600
• Locations: 1 country
• Sites: 1

Brief Summary

Severe symptomatic aortic stenosis (AS) with a high gradient is associated with a poor prognosis if not treated with valve replacement. Transcatheter aortic valve implantation has been shown in large randomized trials to be a safe and effective treatment option for patients at low, intermediate, or high risk. Transfemoral access for heart valve replacement is by far the most commonly used approach, as it is relatively easy to control and has a low complication rate compared to other access routes. The TAVI procedure requires two arterial access points: one with a large lumen for the TAVI prosthesis via the femoral artery, and a smaller second one for a pigtail catheter that guides the TAVI prosthesis into the optimal position. This secondary access is most often via a second artery. Vascular complications are the most commonly observed complications in transfemoral TAVI and are associated with poorer procedural outcomes. Recent data suggest that secondary vascular access via the radial artery may contribute to a reduction in vascular complications after TAVI. In patients undergoing coronary angiography and/or percutaneous coronary intervention, radial access has become the preferred strategy due to its proven reduction in vascular complications compared to femoral access. The use of radial access is associated with a lower incidence of vascular complications compared to femoral access. Recent non-randomized data suggest that radial access may be a safer alternative to traditional femoral access as a secondary arterial access in transfemoral TAVI. However, non-randomized retrospective comparisons are subject to selection bias and underreporting of complications. Therefore, a prospective randomized trial is needed to evaluate the value of radial access for secondary arterial access in patients undergoing transfemoral TAVI.

Conditions

TAVI(Transcatheter Aortic Valve Implantation)

Outcome Measures

Primary Outcomes (1)

• Vascular and bleeding complications related to the secondary vascular access site

  30 days

Secondary Outcomes (1)

• Until 30 days after index procedure:

  30 days

Study Arms (2)

Group 1 Radial

ACTIVE COMPARATOR

Group 1: patients with radial secondary arterial access

Procedure: Radial TAVI

Group 2 femoral

ACTIVE COMPARATOR

Group 2: patients with femoral secondary arterial access

Procedure: femoral TAVI

Interventions

Radial TAVI PROCEDURE

patients will recieve the TAVI intervention via radial access

Group 1 Radial

femoral TAVI PROCEDURE

patients will recieve the TAVI intervention via femoral access

Group 2 femoral

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Patients scheduled for transfemoral TAVI
• Heart team agrees on eligibility of TAVI
• Written informed consent
• Age \> 18 years

You may not qualify if:

• Non accessible radial arteries as judged by the TAVI team
• Non accessible femoral arteries as judged by the TAVI team
• Foreseeable problems to achieve primary transfemoral access (hostile access)
• Hemodynamic instability or cardiogenic shock
• Currently participating in an investigational drug or another device study
• Lack of capability to give informed consent
• Patient refuses TAVI

Sponsors & Collaborators

• University Heart Center Freiburg - Bad Krozingen: lead

Study Sites (1)

University Heart Center - Deparment for Cardiology and Angiology

Freiburg im Breisgau, 79106, Germany

RECRUITING

Central Study Contacts

Constantin von zur Muehlen, MD

CONTACT

+49 761 270 34415; constantin.vonzurmuehlen@uniklinik-freiburg.de

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: November 27, 2025
• First Posted: February 10, 2026
• Study Start: July 1, 2025
• Primary Completion (Estimated): September 30, 2027
• Study Completion (Estimated): December 31, 2028
• Last Updated: June 2, 2026

Record last verified: 2026-06

Data Sharing

• IPD Sharing: Will share

Locations

DE (1)